Y Mabs Therapeutics Inc (YMAB) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Y mabs Therapeutics inc   (NASDAQ: YMAB)


Y Mabs Therapeutics Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Y Mabs Therapeutics Inc's ROI in the second quarter of 2025?
Y Mabs Therapeutics Inc recorded a cumulative net loss of $-22 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -23.41%.

Within the Healthcare sector 324 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2025 quarter, so far to 3107, from total ROI ranking in the first quarter of 2025 at 3248.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM -8.36 % -8.52 % -6.95 % -8.4 % -6.82 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 94 94 96 96 101
Return On Investment (TTM) -23.41 % -29.25 % -29.81 % -23.69 % -23.76 %
YMAB's Overall Ranking # 3107 # 3248 # 2203 # 3313 # 2851
Seq. Investment Change TTM -1.63 % -3.03 % -1.21 % -2.76 % -1.8 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -22 -28 -30 -24 -25

YMAB Company Profile >> Back to YMAB Roi Comparisons >> See Annual YMAB Return On Investment



Return On Investment YMAB's Ranking
Within: No.
Industry # 118
Sector # 325
Overall # 3107

Return On Investment Statistics
High Average Low
-17.53 %
-44.7 %
-106.69 %
(Sep 30 2023)   (Sep 30 2019)







Financial Statements
Y Mabs Therapeutics Inc's II. Quarter Investments $ 94 Millions YMAB's Balance sheet
Y Mabs Therapeutics Inc's II. Quarter Income $ -3 Millions Quarterly YMAB's Income Statement
YMAB's Income by Division See YMAB's Income by Division


YMAB Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 96 101 113 185 107
Y / Y Investment Growth -4.81 % -10.69 % -38.8 % 73.39 % -47.41 %
Net Income in Millions -30 -21 -96 -55 -119
Y / Y Net Income Growth - - - - -
Annual Return On Investment -30.84 % -21.2 % -84.44 % -29.89 % -111.91 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
YMAB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for YMAB's Competitors
Subscribers only: Roi for Y Mabs Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for YMAB's Customers

Other Ratios
YMAB's Roa YMAB's Inventory Turnover Ratio YMAB's Growth Rates YMAB's Dividend Statistics
YMAB's Profitability Ratios YMAB's Asset Turnover Ratio YMAB's Dividend Growth
YMAB's Roe YMAB's Valuation Ratios YMAB's Financial Strength Ratios YMAB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-08-29T17:41:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.